Can This Patient Take A Triptan ? : Review Of The Cardiovascular Safety Of The Triptans And Recommendations For Patient Selection And Evaluation


Background: Treatment guidelines issued in 2001 by the United States Headache Consortium emphasize the use of 5-HT1B/1D agonists (triptans) as preferred agents for abortive treatment of moderate to severe migraine. Despite this, triptans are used by only a minority of patients whose attacks are severe enough to require prescription medication, primarily… (More)


  • Presentations referencing similar topics